Paul R. Edick
Board Member
Vistagen Therapeutics, Inc. (VTGN)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Paul R. Edick
Paul R. Edick is recorded as Board Member at Vistagen Therapeutics, Inc. (VTGN). Vistagen Therapeutics, Inc. reported in an 8-K filed October 29, 2025 that Paul R. Edick was appointed director, effective October 27, 2025.
“On October 27, 2025, the Board of Directors (the "Board") of Vistagen Therapeutics, Inc. (the "Company"), upon recommendation from the Corporate Governance and Nominating Committee of the Board, unanimously approved of the appointment of Mr. Paul R. Edick as a director to serve until the Company's next annual meeting of stockholders or until his successor is duly elected and qualified or until his earlier death, resignation or removal.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-10-27–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Vistagen Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Shawn K. Singh CEO, Board Member
- Cynthia Anderson CFO
- Nick B. Tressler CFO, Chief Accounting Officer
- Joshua Prince COO
- Joshua S. Prince COO
- Reid G. Adler General Counsel
- Douglas J. Williamson, M.D. Board Member
- Joanne Curley, Ph.D. Board Member
- Margaret M. FitzPatrick Board Member
- Mary L. Rotunno Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.